AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 283: E241-E250, 2002. First published March 27, 2002; doi:10.1152/ajpendo.00060.2002
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/2/E241    most recent
00060.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buse, M. G.
Right arrow Articles by Mueckler, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buse, M. G.
Right arrow Articles by Mueckler, M. M.
Vol. 283, Issue 2, E241-E250, August 2002

Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles

Maria G. Buse1,2, Katherine A. Robinson1, Bess A. Marshall3,4, Richard C. Hresko4, and Mike M. Mueckler4

Division of Endocrinology, Departments of 1 Medicine, Diabetes, and Medical Genetics and 2 Biochemistry/ Molecular Biology, Medical University of South Carolina, Charleston, South Carolina 29425; Division of Endocrinology and Metabolism, Departments of 3 Pediatrics and 4 Cell Biology and Physiology, School of Medicine, Washington University, St. Louis, Missouri 63110

O-linked glycosylation on Ser/Thr with single N-acetylglucosamine (O-GlcNAcylation) is a reversible modification of many cytosolic/nuclear proteins, regulated in part by UDP-GlcNAc levels. Transgenic (T) mice that overexpress GLUT1 in muscle show increased basal muscle glucose transport that is resistant to insulin stimulation. Muscle UDP-GlcNAc levels are increased. To assess whether GLUT4 is a substrate for O-GlcNAcylation, we translated GLUT4 mRNA (mutated at the N-glycosylation site) in rabbit reticulocyte lysates supplemented with [35S]methionine. O-GlcNAcylated proteins were galactosylated and separated by lectin affinity chromatography; >20% of the translated GLUT4 appeared to be O-GlcNAcylated. To assess whether GLUT4 or GLUT4-associated proteins were O-GlcNAcylated in muscles, muscle membranes were prepared from T and control (C) mice labeled with UDP-[3H]galactose and immunoprecipitated with anti-GLUT4 IgG (or nonimmune serum), and N-glycosyl side chains were removed enzymatically. Upon SDS-PAGE, several bands showed consistently two- to threefold increased labeling in T vs. C. Separating galactosylated products by lectin chromatography similarly revealed approximately threefold more O-GlcNAc-modified proteins in T vs. C muscle membranes. RL-2 immunoblots confirmed these results. In conclusion, chronically increased glucose flux, which raises UDP-GlcNAc in muscle, results in enhanced O-GlcNAcylation of membrane proteins in vivo. These may include GLUT4 and/or GLUT4-associated proteins and may contribute to insulin resistance in this model.

glucose transporter 4; glucose transporter 4-associated proteins; O-linked glycosylation on serine/threonine with single N-acetylglucosamine of membrane proteins; transgenic mice overexpressing glucose transporter 1 in muscle; rabbit reticulocyte lysate


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. J. Copeland, J. W. Bullen, and G. W. Hart
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E17 - E28.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Fulop, R. B. Marchase, and J. C. Chatham
Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system
Cardiovasc Res, January 15, 2007; 73(2): 288 - 297.
[Abstract] [Full Text] [PDF]


Home page
J Exp BotHome page
L. M. Hartweck, R. K. Genger, W. M. Grey, and N. E. Olszewski
SECRET AGENT and SPINDLY have overlapping roles in the development of Arabidopsis thaliana L. Heyn.
J. Exp. Bot., March 1, 2006; 57(4): 865 - 875.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Buse
Hexosamines, insulin resistance, and the complications of diabetes: current status
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. C. Love and J. A. Hanover
The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
Sci. Signal., November 29, 2005; 2005(312): re13 - re13.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D.-H. Han, M. M. Chen, and J. O. Holloszy
Glucosamine and glucose induce insulin resistance by different mechanisms in rat skeletal muscle
Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1267 - E1272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. L. E. Walgren, T. S. Vincent, K. L. Schey, and M. G. Buse
High glucose and insulin promote O-GlcNAc modification of proteins, including alpha -tubulin
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E424 - E434.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online